Filter
775
Text search:
pandemic
influenza
Featured
Recommendations
106
New Publications
81
Language
Document type
Guidelines
267
No document type
195
Studies & Reports
155
Manuals
54
Strategic & Response Plan
48
Fact sheets
28
Training Material
8
Situation Updates
8
Online Courses
4
Resource Platforms
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
Global
34
Brazil
29
Western and Central Europe
29
Latin America and the Carribbean
28
Russia
24
Germany
22
Eastern Europe and Central Asia
18
India
17
Middle East and North Africa
16
West and Central Africa
14
Sierra Leone
13
East and Southern Africa
13
Liberia
12
Syria
12
Africa
12
Ghana
11
South Africa
10
Mozambique
10
Kenya
8
Bangladesh
8
Angola
8
South–East Asia Region
8
Nepal
7
Yemen
7
Philippines
6
Ukraine
6
Vietnam
6
Nigeria
5
South Sudan
5
Western Pacific Region
5
Guinea
4
Guinea-Bissau
4
Rwanda
4
Ecuador
4
Laos
4
Portugal
4
USA
3
Ethiopia
3
Cambodia
3
Namibia
3
Peru
3
Colombia
3
Chile
3
Paraguay
3
Eastern Europe
3
Spain
3
Senegal
2
Cameroon
2
Uganda
2
Afghanistan
2
Zambia
2
Turkey
2
China
2
Indonesia
2
Sudan
2
Madagascar
2
Myanmar / Burma
2
Venezuela
2
Italy
2
Japan
2
Congo, Democratic Republic of
1
Mali
1
Somalia
1
Pakistan
1
Lebanon
1
Egypt
1
Mauritania
1
North Macedonia
1
Serbia
1
Botswana
1
Bolivia
1
Sri Lanka
1
Asia
1
Bhutan
1
Palestine
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
France
1
Mauritius
1
United Kingdom
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
283
Key Resources
41
Public Health
39
Clinical Guidelines
33
Women & Child Health
13
Pharmacy & Technologies
12
Capacity Building
10
Toolboxes
COVID-19
383
Rapid Response
120
Planetary Health
34
Ebola
29
AMR
22
Global Health Education
13
Refugee
10
Pharmacy
9
Health Financing Toolbox
8
NCDs
8
Conflict
7
HIV
7
TB
6
Specific Hazards
6
Natural Hazards
5
Zika
5
Mental Health
5
Cholera
3
Polio
3
Caregiver
3
NTDs
2
Disability
1
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
Saúde Soc. São Paulo, v.30, n.1, e200450, 2021
Desde março de 2020, quando a Organização Mundial de Saúde declarou que o mundo vivia uma pandemia de covid-19, acompanhamos um quadro sanitário sem precedentes nos últimos 100 anos. As medidas atuais contra a
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global
...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines
...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
La presente publicación describe la evidencia científica disponible sobre la efectividad del uso de mascarillas o respiradores en la prevención y control de infecciones respiratorias virales incluido COVID-19 a nivel comunitario y hospitalario. Se identificaron 778 estudios publicados hasta abril
...
Available in different languages
Infectious diseases cause over one billion human infections per year, with millions of deaths each year globally. Extensive health and financial burden is seen from both established and emerging infectious diseases. Infectious diseases also affect plants and animals, which may pose threats to agricu
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
A rapid review of evidence on the managing the risk of disease emergence in the wildlife trade - World Animal Health Organization (OIE)
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
SARS-CoV-2 infection and pulmonary tuberculosis: analysis of the situation in Peru
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that policies can be tailored to different population groups.
...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
